Skip to main content
. 2023 Aug 10;14:1226591. doi: 10.3389/fneur.2023.1226591

Figure 1.

Figure 1

Patient flow. All patients received at least one dose of 225 mg fremanezumab. Evalution occurred at month 3 (day-61 to day-90).